I am not a regular poster on this board. I know nothing of GTCH other than what can be gleaned from its SEC filings, which are voluminous and fairly transparent. I do have a position in GTCH, which no doubt colors my view--and any reader should take my remarks with a grain of salt.
Here are my thoughts. If you pull up the quote for GTCH on Google Finance, you will see that at a share price of 0.00065 (price at the moment I am writing this), GTCH is listed as having a P/E ratio 0.42. The most remarkable thing about this is that it means GTCH has "earnings" (at least in the accounting sense). A P/E of 0.42 means that a share can be purchased for a price that is less than 50% of the current "earnings" per share--a negative multiple, if you will. GTCH has reported positive earnings driven in part by sales of its Ravenholm venture, and by the RJW settlement (one-time revenue) and by FV changes in derivative liabilities (variable/ephemeral). At the end of the third quarter 2022 (September 30th), GTCH reported (1) positive "earnings" were $2,245,000, contrasted with a LOSS of $32,854,195 in FY 2021; debt reduced to $23,229,020 versus $32,780,029 in FY 2021; sales of $771,446 versus $0 at the end of FY 2021. Because of the huge number of outstanding shares issued in 2022 to weird joint ventures (not a good look), this $2,255,565 in earnings at the end of 3Q 2022 is booked, by virtue of rounding, as "0.00" earnings per share in the quarterly report. GTCH appears not to be touting these positive "earnings" in PRs, I suppose, because they might be a temporary accounting phenomenon and/or ephemeral. But if you do the math, $2,255,565 divided into 1,426,061,998 basic outstanding shares actually is "earnings" 0.00158/share, a truly trivial number ... unless you compare the even more trivial share price of 0.00065/ per share. So, GTCH currently is in the anomalous position of having "earnings" per share that are double the its price per share.
These earnings could be a one-time thing (like the RJW settlement dollars). Might disappear entirely next year, or even revert to massive paper losses if GTCH writes off its weird 2022 joint ventures (as it did its weird Costa Rican joint venture in 2021). But GTCH's reduction of debt in 2022 appears real. GTCH has been and is a precarious stock, poised on a razor's edge because of the unserved debt it carries and the fact that its fully diluted shares (under convertible notes, preferred shares, etc.) are at a shocking 400% of the reported basic outstanding shares. It isn't worth mentioning, much less recommending, to anyone, IMHO, because it could self-immolate at any moment. But I disagree with those posters who think (with some justification!) that GTCH is an outright scam. Its patent activity goes beyond what a normal scam would bother doing. So does it faithful SEC reporting. To me, GTCH appears more like a blind, starving squirrel searching a large open field for the single acorn that could save it. Starvation is the more likely outcome, but I don't think this makes GTCH a scam.
